Anti-inflammatory Activity of Herbal Tablet of Phyllanthus emblica on Carrageenan-induced Paw Edema in Wistar Rats | Zendy

Amulyaratna Behera | Zendy; Himansu Bhusan Samal | Zendy; Dinesh Kumar Sharma | Zendy; Satish Kanhar | Zendy; Atul Kadam | Zendy; Prachi Khamkar | Zendy; Suchismeeta Behera | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Anti-inflammatory Activity of Herbal Tablet of Phyllanthus emblica on Carrageenan-induced Paw Edema in Wistar Rats

Author(s) -

Amulyaratna Behera,

Himansu Bhusan Samal,

Dinesh Kumar Sharma,

Satish Kanhar,

Atul Kadam,

Prachi Khamkar,

Suchismeeta Behera

Publication year - 2021

Publication title -

journal of pharmaceutical research international

Language(s) - English

Resource type - Journals

ISSN - 2456-9119

DOI - 10.9734/jpri/2021/v33i54b33776

Subject(s) - carrageenan , phyllanthus emblica , friability , pharmacology , traditional medicine , edema , chemistry , medicine , drug , surgery , first pass effect

Aim: In the current investigation, tablet dosage form of hydroalcohol extract of leaves of P. emblica was developed and evaluated foranti-inflammatory activities. Methodology: Hydroalcohol extract of leaves of P. Emblica (HPE) was prepared and formulated tablet dosage form. The mechanical properties e.g. hardness, friability, disintegration, and dissolution of tablet were evaluated. Anti-inflammatory activities of HPE (150 mg/kg) and HPE (650 mg) tablets were performed in carrageenan induced hind paw edema in wistar rats. Results: The anti-inflammatory activity was found to be significant in carrageenan inducedpaw edema. HPE (150 mg/kg) and HPE tablets (650 mg) were significantly (p < 0.05) reduced the carrageenan induced paw edemaby 66.41% and 69.43% respectively as compared to carragenan control. The % inhibition of standard drug (dichlorofenac sodium) was recorded to be 70.18% after 5 h. Conclusion: The study standardised the development of HPE tablet and its anti-inflammatory effect.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research